Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Alzheimer disease 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 17件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬 💬
2 AMPK signaling pathway 💬
1件: HMGCR 💬 Simvastatin 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 💬
3 Amyotrophic lateral sclerosis 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 17件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬 💬
4 Bile secretion 💬
1件: HMGCR 💬 Simvastatin 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 💬
5 Complement and coagulation cascades 💬
2件: F10, F9 💬 Emicizumab 💬 Emicizumab 1件: 288 💬 💬
6 Complement and coagulation cascades 💬
1件: F8 💬 Desmopressin 💬 Desmopressin 6件:  6 , 64, 72, 75, 225, 288 💬 💬
7 Complement and coagulation cascades 💬
1件: PLG 💬 Tranexamic acid 💬 Tranexamic acid 7件: 46, 70, 215, 227, 274, 288, 299 💬 💬
8 Cytokine-cytokine receptor interaction 💬
1件: IL11RA 💬 Oprelvekin 💬 Oprelvekin 2件: 96, 288 💬 💬
9 Hematopoietic cell lineage 💬
1件: IL11RA 💬 Oprelvekin 💬 Oprelvekin 2件: 96, 288 💬 💬
10 Hematopoietic cell lineage 💬
1件: MS4A1 💬 Rituximab 💬 Rituximab 48件: 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 💬
11 Huntington disease 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 17件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬 💬
12 Influenza A 💬
1件: PLG 💬 Tranexamic acid 💬 Tranexamic acid 7件: 46, 70, 215, 227, 274, 288, 299 💬 💬
13 JAK-STAT signaling pathway 💬
1件: IL11RA 💬 Oprelvekin 💬 Oprelvekin 2件: 96, 288 💬 💬
14 Metabolic pathways 💬
1件: HMGCR 💬 Simvastatin 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 💬
15 Neuroactive ligand-receptor interaction 💬
1件: AVPR2 💬 Desmopressin 💬 Desmopressin 6件:  6 , 64, 72, 75, 225, 288 💬 💬
16 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Prednisone 💬 Prednisone 45件:  2 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬 💬
17 Neuroactive ligand-receptor interaction 💬
1件: PLG 💬 Tranexamic acid 💬 Tranexamic acid 7件: 46, 70, 215, 227, 274, 288, 299 💬 💬
18 Parkinson disease 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 17件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬 💬
19 Pathways of neurodegeneration - multiple diseases 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 17件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬 💬
20 Phospholipase D signaling pathway 💬
1件: AVPR2 💬 Desmopressin 💬 Desmopressin 6件:  6 , 64, 72, 75, 225, 288 💬 💬
21 Prion disease 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 17件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬 💬
22 Proteasome 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 17件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬 💬
23 Spinocerebellar ataxia 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 17件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬 💬
24 Staphylococcus aureus infection 💬
1件: PLG 💬 Tranexamic acid 💬 Tranexamic acid 7件: 46, 70, 215, 227, 274, 288, 299 💬 💬
25 Terpenoid backbone biosynthesis 💬
1件: HMGCR 💬 Simvastatin 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 💬
26 Vasopressin-regulated water reabsorption 💬
1件: AVPR2 💬 Desmopressin 💬 Desmopressin 6件:  6 , 64, 72, 75, 225, 288 💬 💬